Our study revealed that the methylation levels of the HAND1 CpG site in CRC patients demonstrated a sensitivity of 93.33% (95% CI, 70.18–99.66%) and a specificity of 80.00% (95% CI, 62.69–90.49%), with a cut-off value greater than 1.57. Here, HAND1 is linked to colorectal carcinoma.